The NIHR has established a number of workstreams to support the UK Government's commitment to reduce clinical trial set up times to 150-days or less. Updates on each of these is provided below and will be communicated on a regular basis to delivery organisations and sponsors.
The LIPF provides up to £500m investment to unlock the growth of high potential innovation clusters across the UK. We expect this significant new investment to generate over £1 billion of co-investment and an additional £700 million of value to local economies, including through new jobs, products and services.
Guidance is available for HSC organisations on how to acknowledge a new commercial research project being proposed to a HSC Trust for feasibility assessment under a model Master Confidential Disclosure Agreement (mMCDA).
